Showing 1 - 7 results of 7 for search 'Jan Scicinski', query time: 3.81s Refine Results
  1. 1
    The capacity of red blood cells to reduce nitrite determines nitric oxide generation under hypoxic conditions.

    The capacity of red blood cells to reduce nitrite determines nitric oxide generation under hypoxic conditions. by Marcel H Fens, Sandra K Larkin, Bryan Oronsky, Jan Scicinski, Claudia R Morris, Frans A Kuypers

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets

    Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets by Corey A. Carter, Bryan Oronsky, Scott Caroen, Jan Scicinski, Aiste Degesys, Pedro Cabrales, Tony R. Reid, Christina Brzezniak

    Published 2016-05-01
    Get full text
    Article
  3. 3
    Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor

    Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor by Corey A. Carter, Aiste Degesys, Bryan Oronsky, Jan Scicinski, Scott Z. Caroen, Arnold L. Oronsky, Tony Reid, Pedro Cabrales, Joe Roswarski

    Published 2015-10-01
    Get full text
    Article
  4. 4
    Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance

    Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance by Bryan Oronsky, Corey A. Carter, Tony R. Reid, Jan Scicinski, Arnold Oronsky, Michelle Lybeck, Scott Caroen, Meaghan Stirn, Neil Oronsky, Peter Langecker

    Published 2015-09-01
    Get full text
    Article
  5. 5
    Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001

    Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001 by Corey A. Carter, Bruno Schmitz, P. Gabriel Peterson, Mary Quinn, Aiste Degesys, John Jenkins, Bryan Oronsky, Jan Scicinski, Scott Caroen, Tony R. Reid, Pedro Cabrales, Christina Brzezniak

    Published 2016-03-01
    Get full text
    Article
  6. 6
    Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents

    Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents by Bryan Oronsky, Jan Scicinski, Michelle M. Kim, Pedro Cabrales, Michael E. Salacz, Corey A. Carter, Neil Oronsky, Harry Lybeck, Michelle Lybeck, Christopher Larson, Tony R. Reid, Arnold Oronsky

    Published 2016-07-01
    Get full text
    Article
  7. 7
    Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial

    Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial by Michelle M. Kim, Hemant Parmar, Yue Cao, Priyanka Pramanik, Matthew Schipper, James Hayman, Larry Junck, Aaron Mammoser, Jason Heth, Corey A. Carter, Arnold Oronsky, Susan J. Knox, Scott Caroen, Bryan Oronsky, Jan Scicinski, Theodore S. Lawrence, Christopher D. Lao

    Published 2016-04-01
    Get full text
    Article

Search Tools: